Latest stories on VVOS
Vivos Therapeutics regains Nasdaq stockholders’ equity compliance
The Fly61 · neutralgeneral
Vivos Therapeutics Regains Nasdaq Compliance After Equity Boost
TipRanks62 · neutralgeneral
Vivos Therapeutics reports Nasdaq compliance confirmation with continued listing shareholders’ equity standard
Seeking Alpha58 · neutralgeneral
Vivos Therapeutics, Inc. (VVOS) files 8-K
SEC 8-K50 · neutralgeneral
Vivos Therapeutics Reports Nasdaq Confirmation of Compliance with Continued Listing Shareholders’ Equity Standard
GlobeNewswire58 · neutralgeneral
Vivos Therapeutics Reports Nasdaq Confirmation of Compliance with Continued Listing Shareholders’ Equity Standard
Business Insider58 · neutralgeneral
Vivos Therapeutics, Inc. (VVOS) files 8-K
SEC 8-K50 · neutralgeneral
Vivos Therapeutics to acquire minority stake in SOD Sciences in $12M stock transaction
Seeking Alpha58 · neutralm&a
Vivos Therapeutics Forms Strategic SOD Sciences Partnership
TipRanks58 · neutralproduct/pr
Vivos Therapeutics, Inc. (VVOS) files 8-K
SEC 8-K56 · neutralgeneral
Vivos Therapeutics, Inc. (VVOS) files 8-K
SEC 8-K50 · neutralgeneral
VVOS Jumps as Management Targets $3.60 Million in Annual Cost Cuts and a 3-Fold Referral Surge
September 29, 2026
MarketChameleon63 · neutralgeneral
Vivos Therapeutics Targets $3.6 Million in Annual Cost Reductions as Revenue Growth Initiatives Accelerate
InvestorsHub63 · neutralgeneral
Vivos Therapeutics reports progress in material cost reductions, revenue growth
The Fly63 · neutralproduct/pr
Vivos Therapeutics Reports Progress in Material Cost Reductions and Revenue Growth Initiatives
GlobeNewswire63 · neutralproduct/pr
Vivos Therapeutics Reports Progress in Material Cost Reductions and Revenue Growth Initiatives
Business Insider63 · neutralproduct/pr
8-K/A - Vivos Therapeutics, Inc. (VVOS) files 8-K
SEC 8-K50 · neutralgeneral
Vivos Therapeutics Announces Material Debt Reduction
Business Insider63 · neutralgeneral
Vivos Therapeutics Announces Material Debt Reduction
GlobeNewswire67 · bullishgeneral
Vivos Therapeutics, Inc. (VVOS) files 8-K
SEC 8-K50 · neutralgeneral
Vivos Therapeutics to Present at the 2026 Moody Capital Solutions Disruptive Growth & Life Sciences Conference
StockTitan56 · neutralgeneral
Vivos Therapeutics, SPCVA to launch regional sleep testing and treatment center
The Fly56 · neutralproduct/pr